Private label vs. custom formulation — which path actually scales?

Private label (PLR) uses a manufacturer's existing stock formula under your brand. You choose from their library, customize packaging, and ship in 8–14 weeks.

Custom formulation is bespoke chemistry — you brief, a chemist develops, you iterate across bench batches, stability runs, and pilot production. Timeline: 6–18 months. Cost: $25k–$150k+ before your first commercial run.

You're pre-revenue, the category is unproven for your audience, or you're testing a hook before committing capital. PLR lets you launch in a quarter, validate with paid traffic, and pivot without blowing six figures on a formula no one wanted.

It's also the right call for line extensions — once your hero SKU is proven, PLR is how you fill out a 3-SKU collection without doubling R&D spend.

You've validated demand on PLR (consistent reorder rate, organic UGC, a hero claim that converts), and you're now constrained by the ceiling: another five brands sell your exact formula, your margins are capped by the manufacturer's pricing, and your story has no clinical depth.

That's when custom earns its capital. Defensible IP, better unit economics at scale, and a story you can tell on a PDP that doesn't sound like everyone else's PDP.

Launch one hero SKU on PLR. Validate with 60–90 days of paid social. Reorder at scale and negotiate exclusivity on the formula. Use that revenue to fund custom formulation for the v2 of your hero — same category, sharper claim, defensible chemistry. Then expand the line.

This is the actual sequence behind brands you assume were "custom from day one." They weren't. They were disciplined about when to stop being PLR.